1. Home
  2. CNTA vs CMPO Comparison

CNTA vs CMPO Comparison

Compare CNTA & CMPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • CMPO
  • Stock Information
  • Founded
  • CNTA 2020
  • CMPO 2000
  • Country
  • CNTA United Kingdom
  • CMPO United States
  • Employees
  • CNTA N/A
  • CMPO N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • CMPO Finance: Consumer Services
  • Sector
  • CNTA Health Care
  • CMPO Finance
  • Exchange
  • CNTA Nasdaq
  • CMPO Nasdaq
  • Market Cap
  • CNTA 2.3B
  • CMPO 2.1B
  • IPO Year
  • CNTA 2021
  • CMPO N/A
  • Fundamental
  • Price
  • CNTA $22.52
  • CMPO $22.08
  • Analyst Decision
  • CNTA Strong Buy
  • CMPO Strong Buy
  • Analyst Count
  • CNTA 9
  • CMPO 6
  • Target Price
  • CNTA $31.75
  • CMPO $24.50
  • AVG Volume (30 Days)
  • CNTA 859.3K
  • CMPO 824.7K
  • Earning Date
  • CNTA 11-12-2025
  • CMPO 11-03-2025
  • Dividend Yield
  • CNTA N/A
  • CMPO N/A
  • EPS Growth
  • CNTA N/A
  • CMPO N/A
  • EPS
  • CNTA N/A
  • CMPO N/A
  • Revenue
  • CNTA $15,000,000.00
  • CMPO $160,683,000.00
  • Revenue This Year
  • CNTA N/A
  • CMPO $10.33
  • Revenue Next Year
  • CNTA N/A
  • CMPO $8.81
  • P/E Ratio
  • CNTA N/A
  • CMPO N/A
  • Revenue Growth
  • CNTA 118.88
  • CMPO N/A
  • 52 Week Low
  • CNTA $9.60
  • CMPO $9.24
  • 52 Week High
  • CNTA $25.42
  • CMPO $26.78
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 45.18
  • CMPO 66.01
  • Support Level
  • CNTA $23.45
  • CMPO $19.43
  • Resistance Level
  • CNTA $25.35
  • CMPO $26.78
  • Average True Range (ATR)
  • CNTA 1.37
  • CMPO 1.33
  • MACD
  • CNTA -0.17
  • CMPO 0.12
  • Stochastic Oscillator
  • CNTA 65.90
  • CMPO 39.08

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

About CMPO CompoSecure Inc.

CompoSecure Inc is engaged in designing and manufacturing premium financial cards. The Company's metal payment card technology and Arculus security and authentication capabilities deliver premium branded experiences which enable people to access and use their assets, and ensure trust at the point of a transaction. Its products include Metal Cards and Arculus, a digital security platform. It has two reportable segments: Payment Card and Arculus.

Share on Social Networks: